Research & Knowledge Resources

Discover how GATC Health is revolutionizing healthcare through the integration of AI, multiomics, and advanced predictive analytics.

Publications

Publications

Novel, Artificial Intelligence-based Approaches to the Mitigation and Treatment of Post-Traumatic Stress Disorder (PTSD) in Affected Populations

American Journal of Biomedical Science & Research

December 15, 2024

June 2024

The paper explores innovative AI-based approaches to PTSD treatment using GATC Health's Multiomics Advanced Technology (MAT) platform. The research combines genomics, machine learning, and deep learning to identify biomarkers and develop targeted therapeutics, offering a breakthrough in personalized PTSD treatment and prevention strategies for affected populations, particularly military veterans.

Learning to Discover: The Impact of AI in Preclinical Drug Development

American Journal of Biomedical Science & Research

November 15, 2024

June 2024

The paper examines how machine learning and AI technologies are transforming preclinical drug discovery, highlighting GATC Health's phenotypic drug discovery pipeline that combines deep learning with systems biology approaches to improve drug development efficiency.

AI-Based Predictions of Molecular Target Activity from Blind Chemical Structures

American Journal of Biomedical Science & Research

June 21, 2024

June 2024

The paper evaluates GATC Health's AI platform performance in predicting molecular target activity through blind chemical structure challenges. Using University of California Irvine's validation study, the platform achieved 91% specificity and 86% sensitivity in screening chemical compounds against biological targets.

AI Derived Therapeutic Development for the Treatment of Opioid Use Disorder

bioRxiv

February 28, 2024

June 2024

Research demonstrates how GATC Health's AI platform identified GATC-021, a novel therapeutic compound that successfully reduced fentanyl intake in preclinical studies. The compound, targeting serotonin receptors, showed effectiveness in both male and female subjects without adverse effects, presenting a promising new approach for treating opioid use disorder.

Machine Learning and Augmented Intelligence Enables Prognosis of Type 2 Diabetes Prior to Clinical Manifestation

Current Diabetes Reviews

February 1, 2024

June 2024

The research examines how machine learning and AI can enable early prediction of Type 2 Diabetes before clinical symptoms appear. The study explores current challenges in biomarker identification and proposes novel multi-omics approaches combined with AI to enable more accurate disease prognostication.

Future of Precision Medicine: Artificial Intelligence Guided Polypharmacology and Rational Polypharmacy Interventions

American Journal of Biomedical Science & Research

January 18, 2024

June 2024

The paper discusses how AI technology is revolutionizing precision medicine through polypharmacology approaches, showcasing GATC Health's AI platform for developing multi-target drug combinations with improved safety and efficacy for complex conditions.

Exosomes; a Potential Source of Biomarkers, Therapy, and Cure for Type-1 Diabetes

Biomolecules

October 28, 2023

June 2024

The paper explores exosomes as a novel therapeutic approach for Type 1 Diabetes, examining their regenerative capacity, cell communication role, and potential as biomarkers and drug delivery vehicles. The research focuses on exosomes' functional capabilities in immune regulation and β-cell preservation.

Video Library

Video Library

From Addiction to Innovation: Dr. Steven Lloyd on Fighting the Opioid Crisis with AI

January 9, 2025

6 minutes

Dr. Steven Lloyd shares his journey from addiction recovery to innovation in addiction medicine with AI.

Novel Treatment for Opioid Addiction Presented by Tyrone Lam

February 14, 2023

18 minutes

Tyrone Lam discusses GATC's advanced AI platform for opioid addiction treatment.

GATC Health's role in opioid abatement at the Alabama Summit.

December 12, 2023

3 minutes

NBC15 highlights GATC Health's role in opioid abatement at the Alabama Summit.

Expert Insights

Expert Insights

Contact us

Join Us in Transforming Medicine Through Advanced AI

Join Us in Transforming Medicine Through Advanced AI

We're always on the lookout for like-minded partners committed to making medicine better, more efficient, and safer. Reach out today to see how our specialized AI solutions can be tailored to your needs.

© 2024 GATC Health Corp. All rights reserved.

© 2024 GATC Health Corp. All rights reserved.

© 2024 GATC Health Corp. All rights reserved.